Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study

被引：2

作者：

Nabors, L. B.

Fink, K.

Reardon, D. A.

Lesser, G. J.

Trusheim, J.

Raval, S. N.

Hicking, C.

Picard, M.

Mikkelsen, T.

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Baylor Res Inst, Dallas, TX USA

[3] Duke Univ, Med Ctr, Durham, NC USA

[4] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA

[5] Virginia Piper Canc Inst, Minneapolis, MN USA

[6] Leon Hess Canc Ctr, Brain Tumor Ctr, Long Branch, NJ USA

[7] Merck KGaA, Darmstadt, Germany

[8] Henry Ford Hlth Syst, Detroit, MI USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.tps151

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS151

引用

页数：1